156 related articles for article (PubMed ID: 11082428)
41. Catechol-O-methyltransferase activity in CHO cells expressing norepinephrine transporter.
Percy E; Kaye DM; Lambert GW; Gruskin S; Esler MD; Du XJ
Br J Pharmacol; 1999 Oct; 128(3):774-80. PubMed ID: 10516661
[TBL] [Abstract][Full Text] [Related]
42. Voltammetric studies on mechanisms of dopamine efflux in the presence of substrates and cocaine from cells expressing human norepinephrine transporter.
Chen N; Trowbridge CG; Justice JB
J Neurochem; 1998 Aug; 71(2):653-65. PubMed ID: 9681456
[TBL] [Abstract][Full Text] [Related]
43. Pharmacological properties of the naturally occurring Ala(457)Pro variant of the human norepinephrine transporter.
Paczkowski FA; Bönisch H; Bryan-Lluka LJ
Pharmacogenetics; 2002 Mar; 12(2):165-73. PubMed ID: 11875370
[TBL] [Abstract][Full Text] [Related]
44. Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei.
Ordway GA; Stockmeier CA; Cason GW; Klimek V
J Neurosci; 1997 Mar; 17(5):1710-9. PubMed ID: 9030630
[TBL] [Abstract][Full Text] [Related]
45. Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants.
Galli A; DeFelice LJ; Duke BJ; Moore KR; Blakely RD
J Exp Biol; 1995 Oct; 198(Pt 10):2197-212. PubMed ID: 7500004
[TBL] [Abstract][Full Text] [Related]
46. Norepinephrine transporter expression and function in noradrenergic cell differentiation.
Sieber-Blum M; Ren Z
Mol Cell Biochem; 2000 Sep; 212(1-2):61-70. PubMed ID: 11108137
[TBL] [Abstract][Full Text] [Related]
47. Cardiotoxic properties of cocaine: studies with positron emission tomography.
Volkow ND; Fowler JS; Ding YS
NIDA Res Monogr; 1996; 163():159-74. PubMed ID: 8809858
[TBL] [Abstract][Full Text] [Related]
48. Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles.
Mandela P; Chandley M; Xu YY; Zhu MY; Ordway GA
Neurochem Int; 2010; 56(6-7):760-7. PubMed ID: 20176067
[TBL] [Abstract][Full Text] [Related]
49. A second extracellular site is required for norepinephrine transport by the human norepinephrine transporter.
Wang CI; Shaikh NH; Ramu S; Lewis RJ
Mol Pharmacol; 2012 Nov; 82(5):898-909. PubMed ID: 22874414
[TBL] [Abstract][Full Text] [Related]
50. Nerve growth factor down-regulates the expression of norepinephrine transporter in rat pheochromocytoma (PC12) cells.
Ikeda T; Kitayama S; Morita K; Dohi T
Brain Res Mol Brain Res; 2001 Jan; 86(1-2):90-100. PubMed ID: 11165376
[TBL] [Abstract][Full Text] [Related]
51. Acute morphological effects of cocaine on rat cardiomyocytes.
Vitullo JC; Mekhail NA; Estafanous FG; Khairallah PA; Engelmann GL
Cytobios; 1993; 76(304):31-9. PubMed ID: 8243111
[TBL] [Abstract][Full Text] [Related]
52. Placental norepinephrine transporter development in the ovine fetus.
Bzoskie I; Blount I; Kashiwai K; Humme J; Padbury JF
Placenta; 1997 Jan; 18(1):65-70. PubMed ID: 9032811
[TBL] [Abstract][Full Text] [Related]
53. Chronic cocaine self-administration upregulates the norepinephrine transporter and alters functional activity in the bed nucleus of the stria terminalis of the rhesus monkey.
Macey DJ; Smith HR; Nader MA; Porrino LJ
J Neurosci; 2003 Jan; 23(1):12-6. PubMed ID: 12514195
[TBL] [Abstract][Full Text] [Related]
54. Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine.
Zhao Z; Baros AM; Zhang HT; Lapiz MD; Bondi CO; Morilak DA; O'Donnell JM
Neuropsychopharmacology; 2008 Dec; 33(13):3190-200. PubMed ID: 18418364
[TBL] [Abstract][Full Text] [Related]
55. Selective binding of 2-[125I]iodo-nisoxetine to norepinephrine transporters in the brain.
Kung MP; Choi SR; Hou C; Zhuang ZP; Foulon C; Kung HF
Nucl Med Biol; 2004 Jul; 31(5):533-41. PubMed ID: 15219270
[TBL] [Abstract][Full Text] [Related]
56. The persistent membrane retention of desipramine causes lasting inhibition of norepinephrine transporter function.
Zhu MY; Kyle PB; Hume AS; Ordway GA
Neurochem Res; 2004 Feb; 29(2):419-27. PubMed ID: 15002740
[TBL] [Abstract][Full Text] [Related]
57. Amphetamine reverses or blocks the operation of the human noradrenaline transporter depending on its concentration: superfusion studies on transfected cells.
Pifl C; Agneter E; Drobny H; Sitte HH; Singer EA
Neuropharmacology; 1999 Jan; 38(1):157-65. PubMed ID: 10193907
[TBL] [Abstract][Full Text] [Related]
58. Extracellular loop 3 of the noradrenaline transporter contributes to substrate and inhibitor selectivity.
Lynagh T; Khamu TS; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jan; 387(1):95-107. PubMed ID: 24081522
[TBL] [Abstract][Full Text] [Related]
59. Dual effects of intravenous anesthetics on the function of norepinephrine transporters.
Hara K; Yanagihara N; Minami K; Hirano H; Sata T; Shigematsu A; Izumi F
Anesthesiology; 2000 Nov; 93(5):1329-35. PubMed ID: 11046223
[TBL] [Abstract][Full Text] [Related]
60. Dual phases of functional change in norepinephrine transporter in cultured bovine adrenal medullary cells by long-term treatment with clozapine.
Yoshimura R; Yanagihara N; Hara K; Nakamura J; Toyohira Y; Ueno S; Izumi F
J Neurochem; 2001 May; 77(4):1018-26. PubMed ID: 11359867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
